Clinical characteristics and outcomes of BCMA-targeted CAR-T cell recipients with COVID-19 during the Omicron wave: a retrospective study - Top-Institutions - MDSpire

Clinical characteristics and outcomes of BCMA-targeted CAR-T cell recipients with COVID-19 during the Omicron wave: a retrospective study

  • By

  • Haiqiong Zheng

  • Shi Han

  • Yijin Chen

  • Houli Zhao

  • Rongrong Chen

  • Qiqi Zhang

  • Delin Kong

  • Mingming Zhang

  • Yongxian Hu

  • He Huang

  • February 21, 2025

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology/Oncology
    • Cellular Therapy
    • Infectious Diseases

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology/Oncology
    • Cellular Therapy
    • Infectious Diseases

  • #3

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Hematology/Oncology
    • Cellular Therapy
    • Immunology

  • #4

    First Affiliated Hospital of Zhejiang University School of Medicine
    First Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang

    Key Differentiators

    • Hematology/Oncology
    • Cellular Therapy
    • Infectious Diseases

  • #5

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology/Oncology
    • Cellular Therapy
    • Infectious Diseases

Original Source(s)

Clinical characteristics and outcomes of BCMA-targeted CAR-T cell recipients with COVID-19 during the Omicron wave: a retrospective study

  • by Haiqiong Zheng, Shi Han, Yijin Chen, Houli Zhao, Rongrong Chen, Qiqi Zhang, Delin Kong, Mingming Zhang, Yongxian Hu, He Huang

  • February 21, 2025

Related Content

The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy

Association of ciltacabtagene autoleucel with immune effector cell-associated enterocolitis: insights from a large national database

Safety, immunogenicity, and long COVID outcomes following inactivated COVID-19 vaccine boosters in elderly Chinese: a prospective cohort study